Zubida M. Al-Majdoub

The University of Manchester

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (17)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (5)

Brahim Achour

Assistant Professor

University of Rhode Island

UNITED STATES

View details

Nigel Hodson

The University of Manchester

UNITED KINGDOM

View details

Kayode Ogungbenro

Lecturer

The University of Manchester

UNITED KINGDOM

View details

Daniel Scotcher

The University of Manchester

UNITED KINGDOM

View details

Amin Rostami-Hodjegan

The Director & Professor of Systems Pharmacology

The University of Manchester

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Zubida M. Al-Majdoub

Research Interests

Explore related searches

Contact this professor

Articles (17)

Dealing With Variable Drug Exposure Due to Variable Hepatic Metabolism: A Proof‐of‐Concept Application of Liquid Biopsy in Renal Impairment

Quantitative Proteomics for Translational Pharmacology and Precision Medicine: State of The Art and Future Outlook

Complementarity of two proteomic data analysis tools in the identification of drug-metabolising enzymes and transporters in human liver

Complementarity of two proteomic data analysis tools in the identification of drug-metabolising enzymes and transporters in human liver

Proteomic quantification of receptor tyrosine kinases involved in the development and progression of colorectal cancer liver metastasis

Proteomic quantification of receptor tyrosine kinases involved in the development and progression of colorectal cancer liver metastasis

Toward systems-informed models for biologics disposition: covariates of the abundance of the neonatal Fc Receptor (FcRn) in human tissues and implications for pharmacokinetic modelling

Quantitative Assessment of the Impact of Crohn's Disease on Protein Abundance of Human Intestinal Drug-Metabolising Enzymes and Transporters

A family of QconCATs (Quantification conCATemers) for the quantification of human pharmacological target proteins

Label-Free but Still Constrained: Assessment of Global Proteomic Strategies for the Quantification of Hepatic Enzymes and Transporters

Liquid Biopsy for Patient Characterization in Cardiovascular Disease: Verification against Markers of Cytochrome P450 and P‐Glycoprotein Activities

Examining Physiologically-Based Pharmacokinetic (PBPK) Model Assumptions for Cross-Tissue Similarity of Kcat: The Case Example of Uridine 5'-diphosphate Glucuronosyltransferase (UGT)

In Vitro to In Vivo Extrapolation Linked to Physiologically Based Pharmacokinetic Models for Assessing the Brain Drug Disposition

Quantitative Assessment of the Impact of Crohn's Disease on Protein Abundance of Human Intestinal Drug-Metabolising Enzymes and Transporters

Quantitative Proteomic Map of Enzymes and Transporters in the Human Kidney: Stepping Closer to Mechanistic Kidney Models to Define Local Kinetics

Non-uniformity of Changes in Drug-Metabolizing Enzymes and Transporters in Liver Cirrhosis: Implications for Drug Dosage Adjustment

Inhibition of aggregation of amyloid-β through covalent modification with benzylpenicillin; potential relevance to Alzheimer’s disease

Collaborators (5)

Brahim Achour

Nigel Hodson

Kayode Ogungbenro

Daniel Scotcher

Amin Rostami-Hodjegan

Make your next move.